Endologix LLC announced that Lucas Buchanan has been appointed to the Board of Directors. Lucas Buchanan is currently the Chief Financial Officer and Chief Operating Officer at Silk Road Medical Inc. He is widely recognized for his contributions to Silk Road Medical as the company introduced a new therapy for the treatment of carotid artery stenosis and changed the paradigm for patients with cerebrovascular disease. Mr. Buchanan played a pivotal role in financing the company and scaling its operations, including leading Silk Road?s initial public offering in 2019, and his role has continued to expand.

Prior to Silk Road Medical, Mr. Buchanan?s background includes investing, business development, and operating roles at The Vertical Group, Impax Laboratories, Medtronic, and Ernst & Young. He holds an MBA in Health Care Management from The Wharton School at the University of Pennsylvania and a BA in Economics from Duke University.